Literature DB >> 2213642

Cerebral metabolic and cognitive studies in dementia with frontal lobe behavioral features.

A Kumar1, M B Schapiro, J V Haxby, C L Grady, R P Friedland.   

Abstract

Three subjects with dementia of the Alzheimer type (DAT) with frontal lobe features of behavioral disinhibition were studied using positron emission tomography with [18F]2-fluoro-2-deoxy-D-glucose (18 FDG) and standardized neuropsychological tests. The three subjects showed significant decrements (p less than .05) in relative glucose metabolism (regional/mean gray metabolism) in the orbitofrontal, prefrontal and anterior cingulate regions when compared to healthy controls. Severity-matched subjects with DAT without the associated frontal lobe features did not show the relative reductions in glucose metabolism in these regions when compared to controls. However, on neuropsychological testing of frontal lobe cognitive functions the three subjects did not show decrements that were more severe than those shown by severity-matched DAT patients without the behavioral features. These data demonstrate physiologic dysfunction in specific cortical regions in subjects with behavioral aberrations attributed to these regions and an apparent dissociation between behavioral and cognitive functions of the frontal lobe.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2213642     DOI: 10.1016/0022-3956(90)90050-z

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  12 in total

1.  Frontotemporal dementia and neuropsychology: the value of missing values.

Authors:  H M Smeding; I de Koning
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

Review 2.  Executive control functions in degenerative dementias: a comparative review.

Authors:  L M Duke; A W Kaszniak
Journal:  Neuropsychol Rev       Date:  2000-06       Impact factor: 7.444

Review 3.  Neuropsychiatry of aggression.

Authors:  Scott D Lane; Kimberly L Kjome; F Gerard Moeller
Journal:  Neurol Clin       Date:  2011-02       Impact factor: 3.806

4.  Alzheimer's disease and frontal variant of frontotemporal dementia-- a very brief battery for cognitive and behavioural distinction.

Authors:  Roberta Perri; Giacomo Koch; Giovanni A Carlesimo; Laura Serra; Lucia Fadda; Patrizio Pasqualetti; Carla Pettenati; Carlo Caltagirone
Journal:  J Neurol       Date:  2005-05-23       Impact factor: 4.849

5.  Qualitative neuropsychological performance characteristics in frontotemporal dementia and Alzheimer's disease.

Authors:  J C Thompson; C L Stopford; J S Snowden; D Neary
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

6.  Specificity of changes in cerebral blood flow in patients with frontal lobe dementia.

Authors:  S E Starkstein; R Migliorelli; A Tesón; L Sabe; S Vázquez; M Turjanski; R G Robinson; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-07       Impact factor: 10.154

Review 7.  Clinical diagnostic criteria and classification controversies in frontotemporal lobar degeneration.

Authors:  Katya Rascovsky; Murray Grossman
Journal:  Int Rev Psychiatry       Date:  2013-04

8.  Beta-adrenoceptor density and subtype distribution in cerebellum and hippocampus from patients with Alzheimer's disease.

Authors:  B Lemmer; L Langer; T Ohm; J Bohl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

Review 9.  Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.

Authors:  Gjumrakch Aliev; Mark A Smith; Mark E Obrenovich; Jack C de la Torre; George Perry
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

10.  Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease.

Authors:  Anand K Deo; Soo Borson; Jeanne M Link; Karen Domino; Janet F Eary; Ban Ke; Todd L Richards; David A Mankoff; Satoshi Minoshima; Finbarr O'Sullivan; Sara Eyal; Peng Hsiao; Ken Maravilla; Jashvant D Unadkat
Journal:  J Nucl Med       Date:  2014-05-19       Impact factor: 11.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.